Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Uncertainty continues for NMS as NHS England awaits evaluation

Practice The new medicine service is expected to be extended temporarily for the fourth time at the end of the month while the results of a long-running Nottingham University study into the scheme are pending

NHS England will not grant the new medicine service (NMS) permanent status when the current interim position comes to an end in two weeks time, C+D has learned. Instead the service is expected to be extended on a temporary basis for the fourth time while NHS England awaits the results of a long-running study into the scheme. 


The NMS is expected to be extended temporarily for the fourth time at the end of the month


More on the future of the NMS

NMS interventions fall amid uncertainty over future

NMS granted third extension

Pharmacists must sell NMS beyond funding negotiations

NHS England has received the initial findings from the study, conducted by Nottingham University, but they would not be made public, it said. C+D understands that an announcement on whether the service will continue after March is due next Monday (March 17).

"Headline findings" had been sent to NHS England, with a full evaluation due to be submitted by the end of the month, University of Nottingham lecturer in pharmacy practice Matthew Boyd, who is leading the study, confirmed.


In March 2013, the deadline for the publication of the evaluation had been pushed back from summer last year because of difficulties recruiting patients. But since then the study had "stuck to target", with the last patient recruited in September, Mr Boyd told C+D.


"We have a deadline to report the evaluation by the end of March and then it goes out for academic review. Those academic reviewers may provide comments [or] disagree with what we've said, but the Department of Health thinks it will be ready for publication around the end of May," he added.


Mr Boyd was unable to indicate whether NHS England would wait for the study to be peer-reviewed before deciding whether to commission the service permanently.


In December, PSNC expressed concern that uncertainty about the long-term future of the service had resulted in a fall in interventions. There was a 13 per cent drop in payment claims between July and August following doubts over the future of the service, PSNC figures claimed.


PSNC told C+D last week it had been in discussions with NHS England about the future of the service based on initial findings from the evaluation and expected news "imminently". It continued to stress the need for contractors to have "clarity on the future of the service", it said. 


Do you think the NMS should be granted a temporary extension again?

Comment below or email us at [email protected] You can also find C+D on Twitter, LinkedIn and Facebook

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD016874

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel